A new research by Prof. Nahmias, together with Prof. Benjamin Tanover from Mount Sinai Hospital in New York has led to a significant breakthrough in understanding the modes of action of the SARS-CoV-2 virus.
VenoVision was selected to participate in the inaugural IP² Launchpad Taiwan-Israel Program in 2020. VenoVision was one of only 25 Israeli start-ups chosen to lead the way in exploring opportunities in Taiwan and Asia.
Guide In Medical, a medical device startup, which emerged from Israel BioDesign program received FDA market approval for its innovative IRRIS device. The device facilitates intubation, an essential lifesaving medical medical procedure.